SBIR-STTR Award

Rapid Detection of Bacterial Contamination in Platelets
Award last edited on: 2/6/09

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$910,503
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Ronald J Rieder

Company Information

Biosense Technologies Inc

4 Arrow Drive
Woburn, MA 01801
   (781) 933-3635
   info@biosensetech.com
   www.biosensetech.com
Location: Single
Congr. District: 05
County: Middlesex

Phase I

Contract Number: 1R43FD001643-01A1
Start Date: 9/30/05    Completed: 2/28/06
Phase I year
2005
Phase I Amount
$100,000
The development of a rapid and simple method for the diagnostic testing of pathogenic bacteria in platelet products is proposed. The technical approach is based on a novel implementation of impedance sensing to monitor cellular growth with unprecedented sensitivity and stability. This enables results to be obtained directly from platelet samples within hours with a simple, inexpensive, and easy to use device ideally suited for mass production. The innovative method avoids the need for high cell densities, thus reducing the time from sample collection to detection of bacterial contamination from days to hours. Feasibility of the diagnostic tool will be demonstrated with several of the clinically significant bacterial strains which are often implicated in transfusion-related sepsis.

Thesaurus Terms:
Bacterial Disease, Biohazard Detection, Biomedical Equipment Development, Biosensor, Blood Bank /Supply Contamination, Communicable Disease Diagnosis, Diagnosis Design /Evaluation, Platelet, Rapid Diagnosis Electrical Impedance, Microorganism Growth, Platelet Transfusion, Transplantation Disease Transmission Escherichia Coli, Serratia Marcescens, Staphylococcus Aureus, Staphylococcus Epidermidis, Bioengineering /Biomedical Engineering, Biotechnology, Bioterrorism /Chemical Warfare, Human Tissue

Phase II

Contract Number: 9R44HL090636-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2007
(last award dollars: 2008)
Phase II Amount
$810,503

A new approach for detecting pathogenic bacteria in platelet concentrates rapidly is proposed. Technically, the approach is based on an unconventional implementation of impedance sensing to monitor cellular metabolic responses with exceptional sensitivity and stability. This enables the detection of small numbers of viable aerobic and anaerobic microorganisms in near-real time without the need for grown cultures significantly reducing the time from sample collection to detection results by several days compared to currently in use methods. Feasibility of the approach was successfully demonstrated as part of the Phase I investigation with representative Gram-negative and Gram-positive species commonly implicated in platelet- associated bacterial sepsis. In addition, the ability to make decisive measurements in short time enables the bacterial testing of platelets just prior to transfusion ensuring the safety of the patient and potentially extending platelets shelf life. The proposed Phase II effort focuses on the development of a prototype instrument and testing of contaminated platelets in a realistic setting. The described approach may also be applicable to the detection of bacteria in other blood products. Bacterial contamination is detected in approximately one of every 2000 units of platelets and is implicated as the cause of severe or fatal sepsis in an estimated 150 patients per year in the United States. The proposed rapid test will enable the detection of viable contaminant bacteria in platelet supplies in near-real time both insuring their safe use and extending their useable life-span.

Thesaurus Terms:
bacteria, biomedical equipment development, blood bank /supply contamination, electrical impedance, platelet, rapid diagnosis computer assisted diagnosis, computer system design /evaluation, consumable /disposable biomedical equipment, microorganism growth